Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1168-1172

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verheye, S.
Right arrow Articles by Hanson, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verheye, S.
Right arrow Articles by Hanson, S. R.
Related Collections
Right arrow Catheter-based coronary interventions: stents
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1168.)
© 2000 American Heart Association, Inc.


Thrombosis

Reduced Thrombus Formation by Hyaluronic Acid Coating of Endovascular Devices

Stefan Verheye; Christos P. Markou; Mahomed Y. Salame; Barbara Wan; Spencer B. King, III; Keith A. Robinson; Nicolas A. F. Chronos; Stephen R. Hanson

From the Division of Molecular Medicine(S.V., C.P.M., K.A.R., N.A.F.C., S.R.H.), Yerkes Regional Primate Research Center, Departments of Medicine (S.V., M.Y.S., S.B.K., S.R.H.) and Biomedical Engineering (C.P.M., S.R.H.), Emory University School of Medicine, Atlanta, Ga; Genzyme Corporation (B.W.), Cambridge, Mass; and The Atlanta Cardiovascular Research Institute (K.A.R., N.A.F.C.), Atlanta, Ga.

Correspondence to Stephen R. Hanson, PhD, 1639 Pierce Dr, Room 1129 WMB, Emory University, Atlanta, GA 30322. E-mail shanson{at}emory.edu

Abstract—Biocompatible stent coatings may alleviate problems of increased (sub)acute thrombosis after stent implantation. Hyaluronic acid (HA), a ubiquitous, nonsulfated glycosaminoglycan, inhibits platelet adhesion and aggregation and prolongs bleeding when administered systemically. However, the effects of immobilized HA for reducing stent platelet deposition in vivo are unknown. We therefore quantified the antithrombotic effects of coating stainless steel stents and tubes with HA using an established baboon thrombosis model under physiologically relevant blood flow conditions. HA-coated and uncoated (control) stents (3.5 mm in diameter, n=32) and stainless steel tubes (4.0 mm in diameter, n=18) were deployed into exteriorized arteriovenous shunts of conscious, nonanticoagulated baboons. Accumulation of 111In-radiolabeled platelets was quantified by continuous gamma-camera imaging during a 2-hour blood exposure period. HA coating resulted in a significant reduction in platelet deposition in long (4 cm) tubes (0.24±0.15x109 versus 6.12±0.49x109 platelets; P<0.03), short (2 cm) stainless steel tubes (0.18±0.06x109 versus 3.03±0.56x109 platelets; P<0.008), and stents (0.82±0.20x109 versus 1.83±0.23x109 platelets; P<0.02) compared with uncoated control devices. Thus, HA coating reduces platelet thrombus formation on stainless steel stents and tubes in primate thrombosis models. These results indicate that immobilized HA may represent an attractive strategy for improving the thromboresistance of endovascular devices.


Key Words: thrombosis • stents • hyaluronic acid • baboon




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
E. R. Tamm, R. G. Carassa, D. M. Albert, B. T. Gabelt, S. Patel, C. A. Rasmussen, and P. L. Kaufman
Viscocanalostomy in Rhesus Monkeys
Arch Ophthalmol, December 1, 2004; 122(12): 1826 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. D. Kolodgie, A. P. Burke, A. Farb, D. K. Weber, R. Kutys, T. N. Wight, and R. Virmani
Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions: Insights Into Plaque Erosion
Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1642 - 1648.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. E. Andrew, P. Monagle, G. deVeber, and A. K.C. Chan
Thromboembolic Disease and Antithrombotic Therapy in Newborns
Hematology, January 1, 2001; 2001(1): 358 - 374.
[Abstract] [Full Text] [PDF]